Download
13014_2024_Article_2497.pdf 1,17MB
WeightNameValue
1000 Titel
  • Advances in breast cancer treatment: a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer
1000 Autor/in
  1. Bilski, Mateusz |
  2. Konat-Bąska, Katarzyna |
  3. Zerella, Maria Alessia |
  4. Corradini, Stefanie |
  5. Hetnał, Marcin |
  6. Leonardi, Maria Cristina |
  7. Gruba, Martyna |
  8. Grzywacz, Aleksandra |
  9. Hatala, Patrycja |
  10. Jereczek-Fossa, Barbara Alicja |
  11. Fijuth, Jacek |
  12. Kuncman, Łukasz |
1000 Verlag
  • BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-08-02
1000 Erschienen in
1000 Quellenangabe
  • 19(1):103
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13014-024-02497-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295558/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Abstract Breast conserving treatment typically involves surgical excision of tumor and adjuvant radiotherapy targeting the breast area or tumor bed. Accurately defining the tumor bed is challenging and lead to irradiation of greater volume of healthy tissues. Preoperative stereotactic body radiotherapy (SBRT) which target tumor may solves that issues. We conducted a systematic literature review to evaluates the early toxicity and cosmetic outcomes of this promising treatment approach. Secondary we reviewed pathological complete response (pCR) rates, late toxicity, patient selection criteria and radiotherapy protocols. We retrieved literature from PubMed, Scopus, Web of Science, Cochrane, ScienceDirect, and ClinicalTrials.gov. The study adhered to the PRISMA 2020 guidelines. Ten prospective clinical trials (7 phase II, 3 phase I), encompassing 188 patients (aged 18–75 years, cT1-T3 cN0-N3 cM0, primarily with ER/PgR-positive, HER2-negative status,), were analyzed. Median follow-up was 15 months (range 3–30). Treatment involved single-fraction SBRT (15-21Gy) in five studies and fractionated (19.5–31.5Gy in 3 fractions) in the rest. Time interval from SBRT to surgery was 9.5 weeks (range 1–28). Acute and late G2 toxicity occurred in 0–17% and 0–19% of patients, respectively, G3 toxicity was rarely observed. The cosmetic outcome was excellent in 85–100%, fair in 0–10% and poor in only 1 patient. pCR varied, showing higher rates (up to 42%) with longer intervals between SBRT and surgery and when combined with neoadjuvant systemic therapy (up to 90%). Preoperative SBRT significantly reduce overall treatment time, enabling to minimalize volumes. Early results indicate excellent cosmetic effects and low toxicity. Graphical abstract
1000 Sacherschließung
lokal Preoperative
lokal Female [MeSH]
lokal Preoperative Care [MeSH]
lokal Humans [MeSH]
lokal Breast cancer
lokal SABR
lokal Breast neoplasm
lokal Neoadjuvant
lokal SBRT
lokal Breast Neoplasms/radiotherapy [MeSH]
lokal Breast tumor
lokal Radiosurgery/methods [MeSH]
lokal Radiosurgery/adverse effects [MeSH]
lokal Stereotactic body radiation therapy
lokal Review
lokal Breast Neoplasms/surgery [MeSH]
lokal Tumor bed
lokal Stereotactic ablative body radiotherapy
lokal Breast Neoplasms/pathology [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Qmlsc2tpLCBNYXRldXN6|https://frl.publisso.de/adhoc/uri/S29uYXQtQsSFc2thLCBLYXRhcnp5bmE=|https://frl.publisso.de/adhoc/uri/WmVyZWxsYSwgTWFyaWEgQWxlc3NpYQ==|https://frl.publisso.de/adhoc/uri/Q29ycmFkaW5pLCBTdGVmYW5pZQ==|https://frl.publisso.de/adhoc/uri/SGV0bmHFgiwgTWFyY2lu|https://frl.publisso.de/adhoc/uri/TGVvbmFyZGksIE1hcmlhIENyaXN0aW5h|https://frl.publisso.de/adhoc/uri/R3J1YmEsIE1hcnR5bmE=|https://frl.publisso.de/adhoc/uri/R3J6eXdhY3osIEFsZWtzYW5kcmE=|https://frl.publisso.de/adhoc/uri/SGF0YWxhLCBQYXRyeWNqYQ==|https://frl.publisso.de/adhoc/uri/SmVyZWN6ZWstRm9zc2EsIEJhcmJhcmEgQWxpY2ph|https://frl.publisso.de/adhoc/uri/RmlqdXRoLCBKYWNlaw==|https://frl.publisso.de/adhoc/uri/S3VuY21hbiwgxYF1a2Fzeg==
1000 Hinweis
  • DeepGreen-ID: 723642d78c414b119ce084f870f76546 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6523268.rdf
1000 Erstellt am 2025-07-06T20:27:11.099+0200
1000 Erstellt von 322
1000 beschreibt frl:6523268
1000 Zuletzt bearbeitet 2025-07-29T16:21:35.509+0200
1000 Objekt bearb. Tue Jul 29 16:21:35 CEST 2025
1000 Vgl. frl:6523268
1000 Oai Id
  1. oai:frl.publisso.de:frl:6523268 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source